Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

[1] Imiglucerase (Cerezyme)

[1] Imiglucerase (Cerezyme) 💬

[1] GBA1 💬

[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬

[1] 19 💬

2

Cerezyme (imiglucerase for injection)

[1] Imiglucerase (Cerezyme)

[1] Imiglucerase (Cerezyme) 💬

[1] GBA1 💬

[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬

[1] 19 💬

3

Cerezyme 400 Units Powder for concentrate for solution for infusion

[1] Imiglucerase (Cerezyme)

[1] Imiglucerase (Cerezyme) 💬

[1] GBA1 💬

[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬

[1] 19 💬

4

[1] Imiglucerase (Cerezyme)

[1] Imiglucerase (Cerezyme) 💬

[1] GBA1 💬

[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬

[1] 19 💬

5

Cerezyme® / Imiglucerase

[1] Imiglucerase (Cerezyme)

[1] Imiglucerase (Cerezyme) 💬

[1] GBA1 💬

[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬

[1] 19 💬

6

EU-sourced Cerezyme

[1] Imiglucerase (Cerezyme)

[1] Imiglucerase (Cerezyme) 💬

[1] GBA1 💬

[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬

[1] 19 💬

7

IMIGLUCERASE
(Cerezyme)

[1] Imiglucerase (Cerezyme)

[1] Imiglucerase (Cerezyme) 💬

[1] GBA1 💬

[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬

[1] 19 💬